FANCM and neoplasm: The other case (case 11) was homozygous for FANCM c.5101C > T, had a triple-negative tumor at the age of 65, and suffered from severe fatigue, cytopenia and neutropenic infection during carboplatin/paclitaxel and epirubicin/cyclophosphamide treatments, despite receiving additional leukocyte growth factor.